Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Nov;10(11):e006428.
doi: 10.1161/CIRCIMAGING.117.006428.

Prognostic Stratification of Patients With ST-Segment-Elevation Myocardial Infarction (PROSPECT): A Cardiac Magnetic Resonance Study

Affiliations
Free article
Comparative Study

Prognostic Stratification of Patients With ST-Segment-Elevation Myocardial Infarction (PROSPECT): A Cardiac Magnetic Resonance Study

Gianluca Pontone et al. Circ Cardiovasc Imaging. 2017 Nov.
Free article

Abstract

Background: Cardiac magnetic resonance (CMR) is a robust tool to evaluate left ventricular ejection fraction (LVEF), myocardial salvage index, microvascular obstruction, and myocardial hemorrhage in patients with ST-segment-elevation myocardial infarction. We evaluated the additional prognostic benefit of a CMR score over standard prognostic stratification with global registry of acute coronary events (GRACE) score and transthoracic echocardiography LVEF measurement.

Methods and results: Two hundred nine consecutive patients with ST-segment-elevation myocardial infarction (age, 61.4±11.4 years; 162 men) underwent transthoracic echocardiography and CMR after succesful primary percutaneous coronary intervention. Major adverse cardiac events (MACE) were assessed at a mean follow-up of 2.5±1.2 years. MACE occurred in 24 (12%) patients who at baseline showed higher GRACE risk score (P<0.01), lower LVEF with both transthoracic echocardiography and CMR, lower myocardial salvage index, and higher per-patient myocardial hemorrhage and microvascular obstruction prevalence and amount as compared with patients without MACE (P<0.01). The best cut-off values of transthoracic echocardiography-LVEF, CMR-LVEF, myocardial salvage index, and microvascular obstruction to predict MACE were 46.7%, 37.5%, 0.4, and 2.6% of left ventricular mass, respectively. Accordingly, a weighted CMR score, including the following 4 variables (CMR-LVEF, myocardial salvage index, microvascular obstruction, and myocardial hemorrhage), with a maximum of 17 points was calculated and included in the multivariable analysis showing that only CMR score (hazard ratio, 1.867 per SD increase [1.311-2.658]; P<0.001) was independently associated with MACE with the highest net reclassification improvement as compared to GRACE score and transthoracic echocardiography-LVEF measurement.

Conclusions: CMR score provides incremental prognostic stratification as compared with GRACE score and transthoracic echocardiography-LVEF and may impact the management of patients with ST-segment-elevation myocardial infarction.

Keywords: ST-segment–elevation myocardial infarction; humans; magnetic resonance; prognosis.

PubMed Disclaimer

Comment in

Similar articles

Cited by

  • Ischemic Heart Disease: New Insights from Imaging Diagnostic Techniques.
    Guaricci AI, Galderisi M, Aquaro G, Carrabba N, Gianluca P. Guaricci AI, et al. Biomed Res Int. 2018 Dec 23;2018:5723502. doi: 10.1155/2018/5723502. eCollection 2018. Biomed Res Int. 2018. PMID: 30671460 Free PMC article. No abstract available.
  • Prognostic Value and Therapeutic Perspectives of Coronary CT Angiography: A Literature Review.
    Carità P, Guaricci AI, Muscogiuri G, Carrabba N, Pontone G. Carità P, et al. Biomed Res Int. 2018 Sep 16;2018:6528238. doi: 10.1155/2018/6528238. eCollection 2018. Biomed Res Int. 2018. PMID: 30306089 Free PMC article. Review.
  • Role of CMR Mapping Techniques in Cardiac Hypertrophic Phenotype.
    Baggiano A, Del Torto A, Guglielmo M, Muscogiuri G, Fusini L, Babbaro M, Collevecchio A, Mollace R, Scafuri S, Mushtaq S, Conte E, Annoni AD, Formenti A, Mancini ME, Mostardini G, Andreini D, Guaricci AI, Pepi M, Fontana M, Pontone G. Baggiano A, et al. Diagnostics (Basel). 2020 Sep 29;10(10):770. doi: 10.3390/diagnostics10100770. Diagnostics (Basel). 2020. PMID: 33003571 Free PMC article. Review.
  • Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel.
    Ibanez B, Aletras AH, Arai AE, Arheden H, Bax J, Berry C, Bucciarelli-Ducci C, Croisille P, Dall'Armellina E, Dharmakumar R, Eitel I, Fernández-Jiménez R, Friedrich MG, García-Dorado D, Hausenloy DJ, Kim RJ, Kozerke S, Kramer CM, Salerno M, Sánchez-González J, Sanz J, Fuster V. Ibanez B, et al. J Am Coll Cardiol. 2019 Jul 16;74(2):238-256. doi: 10.1016/j.jacc.2019.05.024. J Am Coll Cardiol. 2019. PMID: 31296297 Free PMC article. Review.
  • Application of AI in cardiovascular multimodality imaging.
    Muscogiuri G, Volpato V, Cau R, Chiesa M, Saba L, Guglielmo M, Senatieri A, Chierchia G, Pontone G, Dell'Aversana S, Schoepf UJ, Andrews MG, Basile P, Guaricci AI, Marra P, Muraru D, Badano LP, Sironi S. Muscogiuri G, et al. Heliyon. 2022 Oct 5;8(10):e10872. doi: 10.1016/j.heliyon.2022.e10872. eCollection 2022 Oct. Heliyon. 2022. PMID: 36267381 Free PMC article. Review.

Publication types

MeSH terms